The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 12.3% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 43%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
Fortescue Ltd
FSUMF · OQX · USD · Market cap $31.6B · 15,745 employees
Fortescue Ltd engages in the exploration, development, production, processing, and sale of iron ore in Australia, China, and internationally.
PASS · Titan Ethical · score 92.1Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 14:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price10.98 USD at the 5 Nov 2026 close
- Our regime readMarkdown, as of 5 Nov 2026
- Ethical screenPasses, score 92.1 out of 100
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-05).
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Fortescue Ltd holds its Markdown at $10.98. The statistical read favours the buyers, held for 4 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the buyers, held for 4 days |
| Price at the screen | $10.98 |
| Valuation | 11.03 trailing · N/A forward price to earnings |
| Values screen | PASS · score 92.1 |
| Beta | 0.69 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 11.40% | Below 33% | Interest-bearing debt is just 11.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 9.39% | Below 33% | Cash held in interest-bearing accounts and securities is 9.4% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.07% | Below 5% | Only 1.1% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Fortescue clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 11%, inside the ~33% line, and interest is about 1% of its income, under the ~5% line, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when FSUMF's ethical verdict changes
Today FSUMF passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
| Trailing P/E | 11.0xreasonably valued |
| EPS, trailing | 0.93 |
| Revenue growth | +7.9%slow but positive growth |
| Profit margin | 16.9%healthy profit margins |
| Return on equity | 14.2%a solid return on shareholder capital |
| FCF yield | 10.03% |
| Dividend yield | 5.12% |
| Debt to equity | 0.29minimal debt: a conservative balance sheet |
| Current ratio | 2.32comfortably covers its short-term bills |
| Beta | 0.69steadier than the market |
| 52-week range | 9.50 - 16.60 |
| Market cap | $31.6B |
| Employees | 15,745 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to Australia and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Titan Case StudyOur full written analysis of FSUMF: FSUMF Case Study → 2026-07-02
Where & How to TradeFSUMF trades on OQX (the company is based in Australia). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.4% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 43%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 43%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 12.1% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 43%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.9% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 43%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 11.7% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 43%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 43%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (92). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with near-perfect ethical score (92). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Can Fortescue (ASX:FMG) Still Trade At A Discount On Earnings? Yahoo Finance · 11d ago
- Fortescue shares hit 16-month low as Q1 iron ore shipments miss estimates Yahoo Finance · 15d ago
- Fortescue Flags Risk to Operations, Guidance If China Talks Drag Past Year-End Yahoo Finance · 16d ago
- World’s first ammonia-powered dry bulk ship completes sea trials Yahoo Finance · 17d ago
- Fortescue sells copper concentrate cleaned with arsenic removal process Yahoo Finance · 18d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-04 | Gaines (Elizabeth Anne) | Director (Executive) | 275,000 | $3,937,312 | |
| 2026-03-30 | Marshall (Larry) | Director (Non-Executive) | 895 | $11,804 | |
| 2026-03-30 | Barnaba (Mark) | Deputy Chairman | 1,474 | · | |
| 2026-02-26 | Barnaba (Mark) | Deputy Chairman | 288 | $4,261 | |
| 2026-02-26 | Marshall (Larry) | Director (Non-Executive) | 4,930 | $72,948 | |
| 2026-02-26 | Rao-Monari (Usha) | Director (Non-Executive) | 287 | $4,246 | |
| 2025-09-26 | Marshall (Larry) | Director (Non-Executive) | 707 | $8,711 | |
| 2025-09-26 | Barnaba (Mark) | Deputy Chairman | 10 | $123 | |
| 2025-09-26 | Barnaba (Mark) | Deputy Chairman | 1,396 | $17,201 | |
| 2025-08-27 | Barnaba (Mark) | Deputy Chairman | 316 | $3,906 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $15.33 | -5.4% | · | $946 | -5.4% |
| 2 months | $15.15 | -4.3% | · | $957 | -4.3% |
| 3 months | $14.30 | +1.4% | · | $1,014 | +1.4% |
| 6 months | $14.66 | -1.1% | $0.63 | $1,032 | +3.2% |
| 1 year | $10.11 | +43.5% | $0.63 | $1,497 | +49.7% |
| 2 years | $13.77 | +5.3% | $1.94 | $1,194 | +19.4% |
| 3 years | $10.41 | +39.2% | $3.87 | $1,764 | +76.4% |
| 5 years | $9.11 | +59.2% | $8.90 | $2,570 | +157.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FSUMF does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.